Esperion Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Esperion Therapeutics

07/05/2024 14:32

* Esperion Therapeutics Inc  ESPR.OQ  reported quarterly
adjusted
earnings of 34 cents​​ per share for the quarter ended in March,
higher than the same quarter last year, when the company
reported EPS of -79 cents.  The mean expectation of
eight analysts for the quarter was for earnings of 5 cents per
share. Wall Street expected results to range from -31 cents
to 46 cents per share.
    * Revenue rose 466.1% to $137.74 million from a year ago;
analysts
expected $83.70 million. 
    * Esperion Therapeutics Inc's reported EPS for the quarter
was 34
cents​.
    * The company reported quarterly net income of $61.02
million.
    * Esperion Therapeutics Inc shares had fallen by 20.9% this
quarter and lost 29.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 216.9%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Esperion
Therapeutics Inc is $8.00 
This summary was machine generated from LSEG data May 7 at 01:31
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      0.05           0.34           Beat
 Dec. 31 2023      -0.48          -0.50          Missed
 Sep. 30 2023      -0.43          -0.37          Beat
 Jun. 30 2023      -0.61          -0.46          Beat